PharVision Advisers’s Ally Financial ALLY Stock Holding History

PharVision Advisers’s Portfolio ALLY Stock Details ALLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,860	Closed	-$265K	–	118
2025 Q4	$265K	Sell	5,860 -6,013	-51%	-$248K	0.13%	353
2025 Q3	$465K	Buy	+11,873	New	+$476K	0.26%	32

Other funds holding ALLY

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PharVision Advisers's ALLY Position: Q1 2026 in Review

PharVision Advisers sold out of Ally Financial (ALLY) in Q1 2026, closing a stake of 5,860 shares — an estimated $265K sold.

PharVision Advisers first reported a position in ALLY in Q3 2025 and held it in 2 quarters. The position peaked at $465K in Q3 2025. 579 funds tracked by Wall St. Rank hold ALLY as of Q1 2026.

PharVision Advisers reported no remaining Ally Financial position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 5,860 Ally Financial shares in Q1 2026, an estimated $265K.
PharVision Advisers first reported a position in Ally Financial in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Ally Financial position peaked at $465K in Q3 2025.
579 funds tracked by Wall St. Rank held Ally Financial as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.